Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted Interest & Investment Income of $1.13 million for Q3 2025, down 40.9% from $1.9 million a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Interest & Investment Income (2013 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Interest & Investment Income at Corbus Pharmaceuticals Holdings was $5.9 million, up 29.9% year-over-year; for FY2024, it was $6.31 million, up 285.8% from FY2023.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 38.7% (FY2019 to FY2024).
- In prior years, Corbus Pharmaceuticals Holdings' Interest & Investment Income was $1.64 million in FY2023.
- The Q3 2025 figure stands as the lowest quarterly Interest & Investment Income since Q1 2024.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $1.31 million (Q2 2025), $1.68 million (Q1 2025) and $1.78 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 50.77 Mn | -465.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Jun 30, 2020 | 12,649.00 |
| Mar 31, 2020 | 101,993.00 |
| Jun 30, 2019 | 448,717.00 |
| Mar 31, 2019 | 334,595.00 |
| Mar 31, 2016 | 1,070.00 |
| Dec 31, 2015 | 1,272.00 |
| Sep 30, 2015 | 1,037.00 |
| Jun 30, 2015 | 548.00 |
| Mar 31, 2015 | 560.00 |
| Dec 31, 2014 | 690.00 |
| Sep 30, 2014 | 802.00 |
| Jun 30, 2014 | 578.00 |
| Mar 31, 2014 | 45.00 |
API Access
Corbus Pharmaceuticals Holdings Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();